Looking Into Bristol-Myers Squibb's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Bristol-Myers Squibb (NYSE:BMY) has seen a decrease in short interest, with the short percent of float dropping 12.88% since the last report. The company has 23.40 million shares sold short, representing 1.15% of available shares. The current short interest is below the peer group average of 3.20%. While a decline in short interest can indicate a more bullish sentiment, it does not necessarily predict a near-term rise in stock price.
November 21, 2023 | 7:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Bristol-Myers Squibb's short interest has decreased, which may indicate a more bullish sentiment among investors. However, this is not a certain predictor of immediate stock price increase.
While a decrease in short interest can be a positive sign for a stock, suggesting that fewer investors are betting on its decline, it is not a definitive indicator of future stock price performance. The short-term impact on BMY's stock price is uncertain, as short interest is just one of many factors that can influence stock prices.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 80